The listing below shows our latest News Items and is updated regularly. If you wish to post a news item please select the 'Post News' button on the right. The displayed news feed starts on 1st August 2016. Older items can be found here.
To 'Post Your News' use the button at the top right.
Outline planning permission application for expansion of the Hoeford Point site now approved.
Wickham Laboratories Holdings, owner of Wickham Laboratories Ltd, today announces approval of its application for planning permission to construct additional buildings on the Hoeford Point site.
Read the rest of entry »
CPI is an independent technology innovation centre that translates ideas, research and knowledge into commercial business propositions by helping companies to develop, prove, prototype and scale up new products and processes at reduced risk.
AMSBIO announces the launch of a new range of induced pluripotent stem cell (iPSC) derived neural stem cells (NSCs) and neural lineage progenitors.
Wickham Laboratories is pleased to announce the publication of a technical editorial “Comparing Endotoxin Detection Methods” which is featured in Pharmaceutical Technology Europe’s November 2017 issue.
Arecor Ltd, the leading formulation technology company, focused on developing superior biopharmaceuticals via the innovative reformulation of proteins and peptides to improve the treatment of diabetes and other conditions, is pleased to announce the launch of its new website
The Company plans to release complete financial and operating results for the fourth quarter and full year 2017 prior to market open on Tuesday, February 27, 2018. At this time, the Company also anticipates providing 2018 financial guidance.
Alta Innovations Ltd, the technology transfer company for the University of Birmingham, announces it has changed its name to University of Birmingham Enterprise Ltd.
On 1 February 2018, J A Kemp, a leading firm of European and UK Patent and Trade Mark Attorneys, will open an office in Paris. T
Summit Therapeutics plc, the drug discovery and development company advancing therapies for rare diseases and infectious diseases, announces that it will present at the Biotech Showcase(TM), taking place 8-10 January in San Francisco, CA, US. The presentation will take place today, 9 January, at 4:00pm PST.
Arecor Ltd, the UK-based leading formulation technology company, focussed on developing superior biopharmaceuticals via the innovative reformulation of proteins and peptides, is pleased to announce the European Patent Office (“EPO”) has issued “Notice of Intention to Grant” for Arecor’s patent application protecting the Company’s proprietary technology used in the development of stable, low-viscosity formulations of highly concentrated protein therapeutics, including monoclonal antibodies such as trastuzumab or ustekinumab or fusion proteins such as abatacept.
OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.
This is an impromptu noticeboard to let people know about events, other things that are happening, perhaps lab equipment for sale etc. Just drop an email to us, firstname.lastname@example.org, and we will post.